Page results
-
We provide a specialist service for the assessment and treatment of sarcoidosis as part of the interstitial lung disease (ILD) service at UCLH. We provide holistic multidisciplinary care, with a weekly consultant-led outpatient clinic and clinical nurse specialist support.
-
We offer an expert service for complex pulmonary embolic disease (PED) and follow up for all cases diagnosed with this condition at UCLH.
-
We provide a comprehensive service from early diagnosis to advanced treatments for severe COPD. We have a strong multidisciplinary team (MDT) including doctors, specialist nurses, physiotherapists, physiologists and psychologists, which enables us to provide holistic, personalised care to each of our patients.
-
This clinic is for asymptomatic travellers (individuals with no current symptoms) who have travelled to a tropical destination and are worried about certain infections.
-
UCLH provides an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia.
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
Preparations for the festive season are in full swing in the UCLH Charity fundraising team.
File results
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023